Parkinson's disease (PD) is a progressive neurological disorder that primarily affects movement. It is characterized by the degeneration of dopamine-producing neurons in the substantia nigra, a part of the brain that controls movement. This article provides a comprehensive overview of PD, its pathophysiology, clinical manifestations, diagnosis, and treatment options.
The primary pathological feature of PD is the loss of dopaminergic neurons in the substantia nigra pars compacta, leading to a decrease in striatal dopamine levels. This results in an imbalance between the excitatory and inhibitory pathways in the basal ganglia, causing the characteristic motor symptoms of PD. The presence of Lewy bodies, abnormal aggregates of the protein alpha-synuclein, is another hallmark of PD.
PD typically presents with motor symptoms such as bradykinesia, resting tremor, rigidity, and postural instability. Non-motor symptoms can include autonomic dysfunction, cognitive impairment, mood disorders, and sleep disturbances. The disease progression varies among individuals, with some experiencing rapid progression while others remain stable for several years.
Diagnosis of PD is primarily clinical, based on the presence of characteristic motor symptoms and response to dopaminergic medication. Neuroimaging can be used to support the diagnosis but is not definitive. Treatment is symptomatic, with levodopa being the most effective medication. Other treatment options include dopamine agonists, MAO-B inhibitors, and deep brain stimulation for advanced cases.
Understanding the pathophysiology, clinical manifestations, and treatment options for Parkinson's disease is crucial for healthcare professionals. Despite the progress made in managing PD, there is still no cure, and the disease continues to pose significant challenges. Continued research and development in this field are necessary to improve the quality of life for individuals living with PD.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation